1
|
Raiss H, El Amarti L, Tigaud JD, Layachi M, Bruyas A, Boutayeb S, Errihani H. Probable paclitaxel-induced pancreatitis: uncommon case report and literature review. J Gastrointest Oncol 2017; 8:E80-E83. [PMID: 29299374 DOI: 10.21037/jgo.2017.08.06] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Acute pancreatitis is an inflammatory disorder of the pancreas characterized by upper abdominal pain, nausea, and vomiting, with elevated serum amylase or lipase. Gallstones and alcohol are the two main etiologies; drug-induced pancreatitis is uncommon. Paclitaxel associated with pancreatitis is very rare and since that time, only seven case reports have been published. We report a case of a 54-year-old female who developed an acute pancreatitis after administration of the first cycle of neoadjuvant chemotherapy with paclitaxel (175 mg/m2 over 3 h) and carboplatin (AUC 6) for ovarian adenocarcinoma. After conservative management, pancreatitis was resolved. The patient received an additional five cycles of carboplatin with no complication. Because Paclitaxel is used in many chemotherapy protocols, it is important for clinicians to be aware that paclitaxel can induce acute pancreatitis, as early diagnosis can be vital.
Collapse
Affiliation(s)
- Hanan Raiss
- Service d'Oncologie Médicale, Institut National d'Oncologie, CHU Rabat and Université Mohamed V, Rabat, Morocco
| | - Lamiae El Amarti
- Service d'Oncologie Médicale, Institut National d'Oncologie, CHU Rabat and Université Mohamed V, Rabat, Morocco
| | - Jean Dominique Tigaud
- Institut de Cancérologie, Hospices Civils de Lyon and Université de Lyon, Lyon, France
| | - Mohamed Layachi
- Service d'Oncologie Médicale, Institut National d'Oncologie, CHU Rabat and Université Mohamed V, Rabat, Morocco
| | - Amandine Bruyas
- Institut de Cancérologie, Hospices Civils de Lyon and Université de Lyon, Lyon, France
| | - Saber Boutayeb
- Service d'Oncologie Médicale, Institut National d'Oncologie, CHU Rabat and Université Mohamed V, Rabat, Morocco
| | - Hassan Errihani
- Service d'Oncologie Médicale, Institut National d'Oncologie, CHU Rabat and Université Mohamed V, Rabat, Morocco
| |
Collapse
|
2
|
El Amarti L, Raiss H, Layachi M, Baldé S, Ettahri H, Elghissassi I, Mrabti H, Errihani H. Breast Adenoid Cystic Carcinoma: A Rare Case Report and Review of the Literature. Gulf J Oncolog 2017; 1:66-69. [PMID: 28798006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/01/2017] [Indexed: 06/07/2023]
Abstract
BACKGROUND Primary adenoid cystic carcinoma (ACC) of the breast is a rare subtype of invasive breast cancer. It has a particular interest because of its excellent prognosis conversely to other triple-negative breast cancers that are associated with poor prognosis. The place of chemotherapy and radiotherapy remains controversial and there is no consensus on optimal management of the ACC of the breast. CASE REPORT A 50-year-old woman, presented with a palpable right breast lump. Core biopsy of the lump revealed an adenoid cystic carcinoma. A lumpectomy with axillary lymph node dissection was performed and completed by a mastectomy because of the positive surgical margins. The histopathological examination revealed an adenoid cystic carcinoma, with negative expression of hormone receptors and human epidermal growth factor receptor 2 HER2 and with no lymph node involvement. The patient underwent adjuvant sequential chemotherapy with anthracycline and taxane followed by radiotherapy. We discuss diagnosis, prognostic, and treatment options for ACC of the breast in light of existing literature. CONCLUSION Adenoid cystic carcinoma of the breast is a rare variant of triple negative breast cancer with excellent prognosis. Surgical treatment is the mainstay with no clear consensus for radiotherapy and chemotherapy.
Collapse
Affiliation(s)
- Lamiae El Amarti
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Hanan Raiss
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Mohamed Layachi
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Salif Baldé
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Hamza Ettahri
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Ibrahim Elghissassi
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Hind Mrabti
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Hassan Errihani
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| |
Collapse
|
3
|
Amarti LE, Faouzi H, Salmi N, Ettahri H, Elghissassi I, Mrabti H, Errihani H. Breast metastasis from recurrent gallbladder adenocarcinoma: a case report with review of the literature. J Gastrointest Oncol 2016; 7:E77-80. [PMID: 27512606 DOI: 10.21037/jgo.2016.03.08] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
Gallbladder adenocarcinoma has a poor prognostic. The leading modes of dissemination in gallbladder cancer (GBC) are lymphatic, vascular, neural, intraperitoneal, and intraductal. The most common site of dissemination is liver. Breast metastasis in GBC is an unusual site of dissemination. Only few cases have been reported in the literature. We report a rare case of solitary breast metastasis from recurrent gallbladder carcinoma in light of existing literature.
Collapse
Affiliation(s)
- Lamiae El Amarti
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco; ; Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Houssin Faouzi
- Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco; ; Department of surgery, National Institute of Oncology, Rabat, Morocco
| | - Nariman Salmi
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco; ; Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Hamza Ettahri
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco; ; Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Ibrahim Elghissassi
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco; ; Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Hind Mrabti
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco; ; Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| | - Hassan Errihani
- Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco; ; Faculty of Medicine and Pharmacy, Mohammed V University, Souissi, Rabat, Morocco
| |
Collapse
|